Utility of parametrectomy for early stage cervical cancer treated with radical hysterectomy
β Scribed by Jason D. Wright; Perry W. Grigsby; Rebecca Brooks; Matthew A. Powell; Randall K. Gibb; Feng Gao; Janet S. Rader; David G. Mutch
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 109 KB
- Volume
- 110
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
BACKGROUND.
Removal of the parametrial soft tissue is recommended for patients with cervical cancer undergoing radical hysterectomy. Parametrectomy results in significant morbidity. The objective of the study was to determine factors predictive of parametrial tumor spread and to define a subset of patients at low risk for parametrial disease.
METHODS.
Patients with invasive cervical cancer who underwent radical hysterectomy from 1989β2005 were examined. Analysis was performed to determine factors associated with parametrial tumor spread. Survival estimates were determined using the KaplanβMeier method.
RESULTS.
A total of 594 patients were identified. Parametrial metastases were documented in 64 (10.8%). Factors associated with parametrial disease were: histology, advanced grade, deep cervical invasion, lymphovascular space invasion (LVSI), large tumor size, advanced stage, uterine or vaginal involvement, and pelvic or paraβaortic lymph node metastases (P < .0001 for each). Parametrial metastases were associated with increased risk of recurrence and decreased diseaseβfree and overall survivals (P < .0001). A subgroup analysis was performed to identify patients at low risk for parametrial spread. In pelvic nodeβnegative women parametrial disease was noted in 6.0% (30/498) compared with 47.9% (34 of 71) of those with positive pelvic nodes (P < .0001). If further stratified to women with negative nodes, no LVSI, and tumors < 2 cm, the incidence of parametrial disease was only 0.4%.
CONCLUSIONS.
Parametrial spread is a strong predictor of recurrence and decreased survival. Parametrial invasion is rare in patients with small tumors, no LVSI, and negative pelvic nodes (no poor prognostic factors). Further study is warranted to determine the feasibility of omitting parametrectomy in these lowβrisk patients. Cancer 2007. Β© 2007 American Cancer Society.
π SIMILAR VOLUMES
## Abstract This study includes 278 cases of stage I and II cervical cancer subjected to radical hysterectomy and lymphadenectomy. The clinical experience of 278 cases is reviewed. Of these cases, 215 were in stage I, and 63 were in stage II. Intraoperative complications occurred at a rate of 9.7%
The authors evaluated the impact of body mass on survival and morbidity of patients with new International Federation of Gynecology and Obstetrics (FIGO) Stage IB1 and IB2 cervical carcinoma managed with radical hysterectomy. ## METHODS. Two hundred twenty-nine patients with Stage IB1 or IB2 cerv
## Abstract ## Background and Objectives The aim of this study was to evaluate type II radical hysterectomy with or without adjuvant therapy as a treatment for patients with pelvic lymph node metastasis (PLNM) and stage IBβIIB cervical carcinoma. ## Methods A total of 288 patients with stage IBβ